Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Editorials

What’s in a Name

Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes

  1. Jerry P. Palmer, MD12 and
  2. Irl B. Hirsch, MD2
  1. 1Veterans Affairs Puget Sound Health Care System, Seattle, Washington
  2. 2Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition, University of Washington, Seattle, Washington
    Diabetes Care 2003 Feb; 26(2): 536-538. https://doi.org/10.2337/diacare.26.2.536
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    Latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes

    Shortly after the original description of islet cell antibodies (ICAs) as a marker for childhood type 1 diabetes, it was realized that some adult-onset patients are also ICA positive (1). With the discovery of GAD antibodies as another marker of type 1 diabetes, Paul Zimmet et al. (2) introduced the term “latent autoimmune diabetes of adults” (LADA) to describe an important minority of adult-onset patients with diabetes. Typical patients are positive for GAD antibodies, 35 years of age or older, nonobese, and present without ketoacidosis and weight loss. Although many maintain good glycemic control for several years with sulfonylureas, these patients become “insulin dependent” more rapidly than antibody-negative type 2 diabetic patients (2).

    Unfortunately, the phenotype of adult-onset diabetic patients, including their presentation, is extremely variable, resulting in confusion with the nomenclature and classification of these patients. Besides LADA, these patients have been named type 1.5 diabetes, “slowly progressive type 1 diabetes,” “latent type 1 diabetes,” “youth-onset diabetes of maturity,” and even LADA-type 1 and LADA-type 2 (3). How should these patients be classified?

    A major question facing the diabetes community is whether all autoantibody-positive diabetes is due to the same pathophysiological disease process. Is autoimmune diabetes in adults due to the same underlying disease process as childhood type 1 diabetes? Or do some patients with autoimmune diabetes in adulthood have a distinct form of autoimmune diabetes compared with classic childhood type 1 diabetes? Phenotypically there are at least three separate populations of autoimmune diabetes in adults: LADA, adult-onset type 1 diabetes, and obese phenotypic type 2 diabetes in patients who are antibody positive.

    In this issue of Diabetes Care, Hosszúfalusi et al. (4) compared patients with LADA with patients presenting with classic type 1 diabetes at older ages. These populations were also compared with a control group …

    View Full Text
    PreviousNext
    Back to top
    Diabetes Care: 26 (2)

    In this Issue

    February 2003, 26(2)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    What’s in a Name
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    What’s in a Name
    Jerry P. Palmer, Irl B. Hirsch
    Diabetes Care Feb 2003, 26 (2) 536-538; DOI: 10.2337/diacare.26.2.536

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    What’s in a Name
    Jerry P. Palmer, Irl B. Hirsch
    Diabetes Care Feb 2003, 26 (2) 536-538; DOI: 10.2337/diacare.26.2.536
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
    • Metformin Therapy During Pregnancy
    • Postprandial Glucose: Marker or Risk Factor?
    Show more Editorials

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.